secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alzamend Neuro, Inc. (ALZN)
CIK:        0001677077
Form:       8-K
Filed at:   2025-03-03T23:59:59+00:00
Accession:  0001214659-25-003727
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alzamend Neuro amends bylaws to lower stockholder quorum to 35%, creates Series C Preferred Stock
--------------------------------------------------------------------------------

- Board reduced quorum for stockholder meetings from majority of outstanding shares to 35%.
- Filed Certificate of Designation for Series C Convertible Preferred Stock with Delaware.
- Series C issuance part of previously disclosed exchange and purchase agreement with a sophisticated investor.
- Exchange of 97.7511 shares of Series A for Series C; up to 500 additional Series C shares to be sold.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925003727/0001214659-25-003727-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1677077/000121465925003727/p312508k.htm
  HTML page:      https://secwatch.observer/filing/0001214659-25-003727

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer